Ignite Creation Date:
2024-05-06 @ 12:53 AM
Last Modification Date:
2024-10-26 @ 10:56 AM
Study NCT ID:
NCT01683084
Status:
COMPLETED
Last Update Posted:
2020-05-26
First Post:
2012-09-05
Brief Title:
Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms
Sponsor:
Palo Alto Veterans Institute for Research
Organization:
Palo Alto Veterans Institute for Research
Study Overview
Official Title:
Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms
Status:
COMPLETED
Status Verified Date:
2020-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TEDY
Brief Summary:
The purpose of this study is to determine if telmisartan is effective in slowing the progression of abdominal aortic aneurysms and reducing circulating concentrations of Abdominal Aortic Aneurysms AAA biomarkers
Detailed Description:
Currently the only management options for AAA are surgical open or endovascular based on ongoing follow-up with imaging at regular intervals Telmisartan is currently approved for use in the United States by the Food and Drug Administration for management of hypertension If telmisartan is found to be effective in slowing the progression of abdominal aortic aneurysms this would provide a new treatment option for patients with AAA disease
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 22647 | OTHER | Stanford IRB | None |